Lung Cancer Biomarkers and Screening Study
This observational study is looking for better ways to find lung cancer early. Researchers want to identify special markers (biomarkers) in your body that could show if you have lung cancer, even before symptoms appear. You might be able to join if you are 50 or older and have a history of smoking, or if you are being evaluated for suspicious lung nodules. The main goal is to see if these biomarkers can help doctors diagnose lung cancer, which will be checked using CT scans and pathology reports. The study is currently unclear on its recruitment status and plans to enroll over 3600 participants.
- Study design
- This is an observational study with an unclear status, planning to enroll 3606 participants. It is not testing a specific drug or intervention.
- What's involved
- You would complete a questionnaire, have lung function tests, a chest CT scan, sputum induction, and blood draws. Some participants might also have a bronchoscopy or lung surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- Lung cancer diagnosis will be measured annually, with the last measurement at 07/01/2015.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Lung Cancer Biomarkers and Screening
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- James J. Tsay, MD, MSc · PRINCIPAL_INVESTIGATOR · NYU Langone Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Lung cancer diagnosis as measured by CT scan findings and pathology findings annually07/01/2015